Skip to main content

Patrick A. Ryscavage, MD

Academic Title:

Assistant Professor

Primary Appointment:

Medicine

Secondary Appointment(s):

Pediatrics

Administrative Title:

Chief, Infectious Disease Inpatient Services -- Midtown Campus

Additional Title:

Associate Medical Director, Center for Infectious Diseases

Location:

725 West Lombard St. S320

Phone (Primary):

410-706-0400

Education and Training

Medical School- Georgetown University School of Medicine
Residency- Georgetown University Medical Center
Fellowship- Northwestern University School of Medicine

Research/Clinical Keywords

HIV, health care transition, adolescents and young adults, immunocompromised hosts

Highlighted Publications

Ryscavage P, Anderson E, Sutton S, Reddy S, Taiwo, B. Clinical outcomes of adolescents and young adults in adult HIV care. J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):193-7.

Bhatia R, Ryscavage P, Taiwo B. Accelerated aging and human immunodeficiency virus infection: Emerging challenges of growing older in the era of successful antiretroviral therapy. J Neurovirol. 2012 Aug;18(4):247-55.

Yanik EL, Napravnik S, Ryscavage P, Eron JJ, Koletar SL, Moore RD, Zinski A, Cole SR, Hunt P, Crane HM, Kahn J, Mathews WC, Mayer K, Taiwo B.  Hematologic, Hepatic, Renal and Lipid Laboratory Monitoring Following Initiation of Combination Antiretroviral Therapy in the United States, 2000-2010. J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):216-20.

Taiwo B, Yanik EL, Napravnik S, Ryscavage P, Koletar SL, Moore R, Mathews WC, Crane HM, Mayerr K, Zinski A, Kahn JS, Eron JJ. Evidence for risk-stratification when monitoring for toxicities following initiation of combination antiretroviral therapy. AIDS. 2013 Jun 19;27(10): 1593-602.

Taiwo B, Acosta EP, Ryscavage P, Berzins B, Lu D, Lalezari J, Castro J, Adeyemi O, Kuritzkes DR, Eron JJ, Tsibris A, Swindells S. Virologic Response, Early HIV-1 Decay and Maraviroc Pharmacokinetics with the Nucleos(t)ide-free Regimen of MaravIroc plus Darunavir/ritonavir in a Pilot Study. J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):167-173.

Ryscavage P, Taiwo B. Viral load diagnostics. HIV Specialist. 2013;5(3): 10-16.

Ryscavage P, Kelly S, Li JZ, Harrigan PR, Taiwo B. Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients. Antimicrob Agents Chemother. 2014 Jul;58(7):3585-98.

Adejumo OA, Malee KM, Ryscavage P, Hunter SJ, Taiwo BO. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review. J Int AIDS Soc. 2015 Sep 16;18(1):20049.

Taremi M, Kleinberg ME, Wang EW, Gilliam BL, Ryscavage PA. Galactomannan antigen detection using bronchial wash and bronchoalveolar lavage in patients with hematologic malignancies. Ann Clin Microbiol Antimicrob. 2015 Nov 14;14(1):50.

Ryscavage P, Macharia T, Patel D, Palmeiro R, Tepper V. Linkage to and retention in care following healthcare transition from pediatric to adult HIV care. AIDS Care. 2016 May;28(5):561-5.

Ryscavage P, Macharia T, Trinidad LR, Lovelace S, Tepper V, Redfield R. Patterns of Systemic Hypertension Among Adults With Perinatally Acquired HIV. J Int Assoc Provid AIDS Care. 2017. Jan/Feb;16(1):3-7.

Tepper V, Zaner S, Ryscavage P. HIV healthcare transition outcomes among youth in North America and Europe: a review. J Int AIDS Soc. 2017 May 16;20(Suppl 3):60-70.

Weld ED, Rana MS, Dallas RH, Camacho-Gonzalez AF, Ryscavage P, Gaur AH, Chakraborty R, Swindells S, Flexner C, Agwu AL. Interest of youth living with HIV in long-acting antiretrovirals.  J Acquir Immune Defic Syndr. 2019 Feb 1;80(2):190-197.

Wu L, Schumacher C, Chandran A, Fields E, Davis M, Ryscavage P, Jones J, Page K, Arrington-Sanders A, Tepper V, Farley J, Greenbaum A, Jennings J. Patterns of HIV pre-exposure prophylaxis one year after intitiating PrEP, Baltimore City, Maryland 2015-2018. Sex Transm Infect 2019;95(Suppl 1):A61.

Ryscavage P, Still W, Nyemba V, Stafford K. Prevalence of systemic hypertension among HIV-infected and HIV-uninfected young adults in Baltimore, Maryland. Southern Med Journal 2019. 112(7):387-391

Schumacher C, Wu L, Chandran A, Fields E, Price A, Greenbaum A, Page K, Davis M, Ryscavage P, Jones J, Farley J, Arrington-Sanders R, Tepper V, Demissew M, Jennings J. STI Screening among Gay, Bisexual and Other Men who Have Sex with Men Prescribed PrEP in Baltimore City, Maryland. Clinical Infectious Diseases. 2020; 71(10): 2637-44.

Ryscavage P, Herbert L, Roberts B, Cain J, Lovelace S, Houck D, Tepper V. Stepping up: retention in HIV care within an integrated health care transition program. AIDS Care. 2021 Apr 9:1-5.

 

 

 

 

Additional Publication Citations

Ryscavage P, Galvin S. Papular-Purpuric Gloves and Socks Syndrome: Case Report and Review. Infect Dis Clin Pract 2010;18: 128-131.

Berg N, Ryscavage P, Kulesza, P. The utility of fine needle aspiration for diagnosis of extrapulmonary coccidioidomycosis: a case report and discussion. Clinical Medicine & Research. 2011. 9(3): 130-133.

Ryscavage P, Noskin G, Bardowski L, Bobb A, Zembower T.  Incidence and impact of false positive urine pneumococcal antigen screening in hospitalized patients. South Med J. 2011 Aug;104(8):593-7.

 

Research Interests

Dr. Ryscavage's research interests include HIV care and prevention, HIV health care transition, HIV care among young adults and adults with perinatally-acquired HIV, and infectious diseases in immunocompromised hosts.

Clinical Specialty Details

Dr. Ryscavage specializes in HIV/AIDS clinical care, HIV prevention, and infectious diseases in immuncompromised hosts.